VPC-3033
VPC-3033 is an androgen receptor antagonist. VPC-3033 has a strong androgen DHT replacement potency (IC50: 0.625-2.5 μM), can effectively inhibit androgen receptor transcriptional activity (IC50=0.3 μM), and has a strong androgen receptor degradation ability. In addition, VPC-3033 exhibits significant anti-androgen receptor activity against prostate cancer cells resistant to Enzalutamide (HY-70002) [1].
Product Specifications
CAS Number
[110763-24-1]
UNSPSC
12352005
Target
Androgen Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Cancer; Endocrinology
Assay Protocol
https://www.medchemexpress.com/vpc-3033.html
Smiles
O=C1C2=C(/C(C3=C1C=CC=C3)=C\C4=CC(O)=CC=C4)C=CC=C2
Molecular Formula
C21H14O2
Molecular Weight
298.33
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal LPAR1/LPA1/EDG-2 Antibody (OTI1G6) [Allophycocyanin/Cy7]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Mouse Monoclonal LPAR1/LPA1/EDG-2 Antibody (OTI1G6) [Allophycocyanin/Cy7]
Recombinant Dictyostelium discoideum putative uncharacterized GPI-anchored protein DDB_G0275411 (DDB_G0275411)
Recombinant Dictyostelium discoideum putative uncharacterized GPI-anchored protein DDB_G0275411 (DDB_G0275411)
Recombinant Dictyostelium discoideum putative uncharacterized GPI-anchored protein DDB_G0275411 (DDB_G0275411)
Recombinant Dictyostelium discoideum putative uncharacterized GPI-anchored protein DDB_G0275411 (DDB_G0275411)